David Daly - 04 Mar 2022 Form 4 Insider Report for Singular Genomics Systems, Inc.

Role
President and Chief Operating
Signature
/s/ Dalen Meeter, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
04 Mar 2022
Net transactions value
$0
Form type
4
Filing time
08 Mar 2022, 18:03:38 UTC
Previous filing
12 Nov 2021
Next filing
14 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Employee Stock Option (right to buy) Award $0 +125,000 $0.000000* 0 04 Mar 2022 Common Stock 125,000 $7.50 Direct F1
transaction OMIC Employee Stock Option (right to buy) Award $0 +125,000 $0.000000* 0 04 Mar 2022 Common Stock 125,000 $7.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares vest and become exercisable in 48 equal monthly installments measured from March 4, 2022.
F2 Subject to the achievement of certain performance targets by December 31, 2022, 25% of the option shares will vest and become exercisable on March 4, 2023, and the remaining option shares will vest and become exercisable in 36 equal monthly installments thereafter as the Reporting Person continues to provide services to the Issuer.